Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Patrick Yeramian
Linked companies : BioVie Inc.
Patrick Yeramian occupies the position of Chief Medical Officer for BioVie, Inc.

He is also General Manager at Dlx Therapeutics L L C.

Dr. Yeramian previously held the position of Chief Medical Officer for Viragen, Inc., Medical Director of Marker Therapeutics, Inc., Medical Director of Kantum Pharma, Inc., Medical Director at Pfizer Inc. and Director-Clinical Research at G.D. Searle & Co. Ltd. (a subsidiary of Pfizer Inc.) and Medical Director of Vaccine & Gene Therapy Institute of Florida Corp.

Dr. Yeramian received a doctorate from Universite Paris Est Creteil Val De Marne, a graduate degree from UniversitÚ de Paris XI Paris Sud and an MBA from Rutgers Business School.

Current positions of Patrick Yeramian 
NameTitle Since
BioVie Inc.
(Biotechnology & Medical Research)
Chief Medical Officer 2018
Dlx Therapeutics L L C General Manager 2018

Patrick Yeramian: Personal Network 
Most Read News 
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
More news

© 2021 People and Ownership :   
Patrick Yeramian : Connections